Results 51 to 60 of about 33,171 (260)
The Impact of Current Treatment on The Symptomatology and Complications of Patients with Polycythemia Vera [PDF]
Documenta HaematologicaIntroduction: polycythemia vera is a Ph-negative relatively indolent chronic myeloproliferative disease, with a high risk of arterial and venous thrombosis, affecting patient survival.
Marc-Tudor DAMIAN +2 more
doaj +1 more source
Studies on the iron metabolism of erythroblasts in various blood diseases [PDF]
, 1960 The serum iron contents and the number of sideroblasts from various patients and the radioactivity of erythroblasts from the same patients incubated with Fe55 have been observed.
Kimura, Ikuro +2 more
core +1 more source
International Journal of Gynecology &Obstetrics, EarlyView.Abstract Background The prevalence of iron deficiency with anemia and iron deficiency without anemia (IDWA) during pregnancy have not been summarized, and evidence of the direct association of IDWA with adverse perinatal outcomes (APO) are unknown.
Lucky O. Lawani +6 more
wiley +1 more source
Isolated cerebellar infarction in a case of JAK 2 mutation-negative polycythemia vera: A case report
Brain Circulation, 2022 Polycythemia vera is a myeloproliferative disorder caused by clonal expansion of erythroid precursors in the bone marrow commonly due to a mutation in the Janus kinase 2 (JAK2) gene located in the short arm of chromosome 9. Hyperviscosity of blood due to
Prasad Krishnan
doaj +1 more source
Systemic Absorption and Pharmacokinetics of Five Novel Topical Dermatologic Agents: A Review
JEADV Clinical Practice, EarlyView.ABSTRACT In recent years, innovative topical medications with novel mechanisms of action have emerged to treat common dermatologic conditions such as acne, atopic dermatitis, vitiligo, and actinic keratoses. These molecularly targeted therapies offer improved safety and tolerability compared to traditional options like corticosteroids.
Mary Dyson +4 more
wiley +1 more source
The symptomatic treatment of polycythemia vera [PDF]
, 1933 Thesis (M.A.)--Boston ...
Johnson, Lorand Victor
core +1 more source
Differential NOD/SCID mouse engraftment of peripheral blood CD34 + cells and JAK2V617F clones from patients with myeloproliferative neoplasms [PDF]
, 2010 We evaluated the NOD/SCID engraftment of CD34 + cells from polycythemia vera (PV) and secondary polycythemia patients (SP) and the JAK2V617F clone before and after transplantation. Peripheral blood CD34 + cells were transplanted intra-femorally.
Cheung, AMS +4 more
core +1 more source
Movement Disorders Clinical Practice, EarlyView.ABSTRACT Background Classifying abnormal tongue movements is challenging due to their varied presentations and limited visibility compared to other body parts. Accurate identification of the phenomenology guides physical examination and can point to specific diagnoses.
Nathaniel Bendahan +4 more
wiley +1 more source
Polycythemia: A Clinical Approach
Jurnal Penyakit Dalam Indonesia, 2019 Polycythemia or erythrocytosis is an increase in the number of red blood cells in circulation marked by the increase in hematocrit. Polycythemia is a case that still raises questions and dilemma for doctors.
Rahmat Cahyanur, Ikhwan Rinaldi
doaj +1 more source
S1‐Guideline for diagnosis and therapy of necrobiosis lipoidica
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.Summary Necrobiosis lipoidica (NL) is a rare granulomatous skin disease of unknown etiology that occurs frequently in association with diabetes mellitus and other comorbidities. The predilection site is the lower leg, particularly the pretibial areas. The exact pathogenesis remains unclear.
Cornelia Erfurt‐Berge +6 more
wiley +1 more source